U.S. Equities Navigate 2026 Restructuring and M&A: A Numbers-Driven Sector RoundupGlobal Report·1 day ago, 04:18 AMALK+2.58%UBSFY+7.11%
Mid-Cap Tech and Healthcare Face Critical Tests: From Delisting Risks to Mega FinancingsGlobal Report·1 day ago, 04:15 AMCYCU-9.34%BJDX+2.91%
The Fragmentation of Innovation: Why Niche Markets Matter This SummerGlobal Report·2 days ago, 04:13 AMSTDN-3.98%CAPR-61.62%
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy MiddleGlobal Report·Jul 24 at 04:13 AMNLST-6.40%HKPD+5.56%
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis StudyTip Ranks·Jul 22 at 04:48 PMBJDX+2.91%
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% ownerPUBT·Jul 22 at 12:30 PMBJDX+2.91%BAC+0.28%
Bluejay Diagnostics announces SYMON-II sepsis study enrollment completionPUBT·Jul 21 at 05:32 AMBJDX+2.91%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 07:05 AMBRNS-0.33%VBIO-5.05%
MedTech Restructuring Accelerates Against the Backdrop of Macro Capital PressuresGlobal Report·Jul 19 at 04:12 AMDHR+1.30%AVTR+3.23%
Compute, Security, and Capital Abstraction: The 2026 Infrastructure Value ChainGlobal Report·Jul 18 at 04:12 AMPURR+2.83%SRXH-4.44%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 17 at 04:05 PMADVB-11.22%ALPS-0.26%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 14 at 07:05 AMBJDX+2.91%PLRZ-4.22%
HRT Financial LP sells 34,938 Bluejay Diagnostics shares for $48,913.20PUBT·Jul 13 at 02:15 PMBJDX+2.91%
